← All trials
NCT05015426
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 13, 2021
- Primary completion
- Dec 31, 2022
- Completion date
- Dec 31, 2024
- First posted
- Aug 20, 2021
- Last posted
- Aug 30, 2021
- Enrollment
- 32
- Arms / groups
- 5 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of South FloridaLead sponsor
- University of South FloridaOverall official - principal investigator
- Florida Department of HealthCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.